Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01753999 · ClinicalTrials.gov registry record · NA

Obstructive Sleep Apnea in World Trade Center Responders

A NA study of Obstructive Sleep Apnea, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
317
Enrollment target
3
Study locations

NCT01753999 is a NA study of Obstructive Sleep Apnea that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 317 participants, above the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (44% higher). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01753999, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
317 participants
Enrollment target
3
Study locations

Study Summary

The goal of the study is to examine the possible underlying causes of sleep apnea (a disorder in which there are problems with breathing during sleep) in World Trade Center Responders. The study will look at the relationship between sleep apnea and various nose and throat conditions. Specifically, the study will look at upper airway disease (problems with the nose and throat), nasal inflammation, and nasal resistance (the amount of airflow through the nose). Subjects will have a physical exam and answer questions about nasal symptoms and sleeping problems. Nasal lavage (washing the inner nasal passages) will be performed on the subjects and markers of inflammation will be measured in the lavage fluid. Rhinomanometry (measuring the airflow through the nose) will also be performed to measure the degree of airflow obstruction. All subjects will be asked to perform in-home sleep apnea monitoring. Those subjects who are diagnosed with sleep apnea will test two treatment methods. Sleep apnea is treated by using a CPAP (continuous positive airway pressure) device. This device blows air into a mask worn by the patient during sleep. The two treatment methods that will be tested are the fixed pressure CPAP (pressure is constant during use) and CPAP-flex (pressure decreases when the subject exhales). Patients will be randomly assigned to one treatment method for one month then crossed to the other treatment method for the next month. The investigators will determine if patients with certain nasal conditions (high nasal resistance) are more likely to use CPAP-flex rather than CPAP.

Conditions Studied

Interventions

  • DEVICE Standard CPAP
  • DEVICE CPAP - Flex

Study Locations (3)

New York

  • New York University School of Medicine Clinical Center of Excellence - New York
  • Mount Sinai School of Medicine - New York

New Jersey

  • Environmental and Occupational Health Sciences Institute - Piscataway

Trial Details

FieldValue
Enrollment Target 317 participants
Start Date 2012-12
Est. Completion 2017-03
Phase NA

What the Registry Record Tells You About NCT01753999

The ClinicalTrials.gov registry entry for NCT01753999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 317 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (44% higher). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Standard CPAP is the first listed.

NCT01753999 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT01753999 about?

NCT01753999 is a clinical study titled "Obstructive Sleep Apnea in World Trade Center Responders". The goal of the study is to examine the possible underlying causes of sleep apnea (a disorder in which there are problems with breathing during sleep) in World Trade Center Responders. The study will look at the relationship between sleep apnea and various nose and throat conditions. Specifically, t...

What is the current status of trial NCT01753999?

This trial is currently completed. It is a NA study. The enrollment target is 317 participants. The study started on 2012-12. Estimated completion is 2017-03.

What conditions does trial NCT01753999 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT01753999?

The interventions under investigation include: Standard CPAP (DEVICE), CPAP - Flex (DEVICE).

Who is sponsoring clinical trial NCT01753999?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01753999 being conducted?

This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.